Spatial analysis of NOS2 and COX2 interaction with T-effector cells reveals immunosuppressive landscapes associated with poor outcome in ER- breast cancer patients
Lisa A. Ridnour(National Institutes of Health), David A. Wink(National Cancer Institute)
Cited by 2
Related Papers
The multifaceted roles of nitric oxide in cancer
|Carcinogenesis|1998|682
Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumors
|JCI Insight|2024|7
NOS2 and COX2 Provide Key Spatial Targets that Determine Outcome in ER-Breast Cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2023|1